Kose, DoganKoksal, Yavuz2020-03-262020-03-2620130888-00181521-0669https://dx.doi.org/10.3109/08880018.2013.797063https://hdl.handle.net/20.500.12395/29888Hyperleukocytosis may be associated with an early morbidity and mortality due to leukostasis. Cytoreductive therapies-such as steroids, hydroxiurea, exchange transfusion, and leukapheresis-have been used for the prevention of leukostasis. Herein, the valproic acid used for the treatment of the hyperleukocytosis did not respond to known therapies in a child; lymphoblastic lymphoma developed bone marrow relapse under the treatment is discussed.en10.3109/08880018.2013.797063info:eu-repo/semantics/closedAccesschildrenhyperleukocytosisvalproic acidLetter30658358523659619Q3WOS:000323110300012Q3